YAP1 and neoplasm: In human tumors, failure to activate LATS1 due to either GNAQ mutations in uveal melanoma or through inactivation of NF2/merlin in the tumor-prone neurofibromatosis syndrome prevent this inhibitory signal and make YAP1 permissive for activation [1].